List of MedeAnalytics SubPop Health Customers
Richardson, 75080, TX,
United States
Since 2010, our global team of researchers has been studying MedeAnalytics SubPop Health customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased MedeAnalytics SubPop Health for Predictive Analytics from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using MedeAnalytics SubPop Health for Predictive Analytics include: Blue Shield of California, a United States based Insurance organisation with 7800 employees and revenues of $27.44 billion, Blue Cross & Blue Shield of Rhode Island, a United States based Insurance organisation with 1100 employees and revenues of $2.05 billion, Concerto Healthcare, Inc, a United States based Healthcare organisation with 200 employees and revenues of $25.0 million and many others.
Contact us if you need a completed and verified list of companies using MedeAnalytics SubPop Health, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The MedeAnalytics SubPop Health customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Blue Cross & Blue Shield of Rhode Island | Insurance | 1100 | $2.1B | United States | MedeAnalytics | MedeAnalytics SubPop Health | Predictive Analytics | 2020 | n/a |
In 2020, Blue Cross & Blue Shield of Rhode Island expanded its partnership with MedeAnalytics and deployed MedeAnalytics SubPop Health to strengthen payer analytics and employer reporting. The deployment targeted Stop Loss reporting and enhanced employer reporting capabilities, aligning the MedeAnalytics SubPop Health implementation with Predictive Analytics use cases focused on identifying high-cost members and flagging trigger diagnoses within Rhode Island.
The implementation configured employer-oriented reporting and Stop Loss reporting modules, combined with predictive risk stratification and cohort identification workflows typical of Predictive Analytics platforms. Reporting dashboards and analytic models were provisioned to surface high-cost member cohorts and diagnosis triggers, enabling payer-facing case identification and employer reporting workflows.
Operational scope centered on payer analytics and employer reporting functions at Blue Cross & Blue Shield of Rhode Island, with the renewed partnership driving expanded usage across those business functions. The workstream emphasized updated reporting cadence and analytic governance tied to the MedeAnalytics SubPop Health deployment, with stated outcomes of improving payer analytics and cost-control capabilities in Rhode Island.
|
|
|
Blue Shield of California | Insurance | 7800 | $27.4B | United States | MedeAnalytics | MedeAnalytics SubPop Health | Predictive Analytics | 2010 | n/a |
In 2010, Blue Shield of California implemented MedeAnalytics SubPop Health, a Predictive Analytics application, to provide payer-facing medical management and claims transparency analytics. The deployment targeted visibility into utilization across inpatient and outpatient settings for clinicians responsible for utilization review.
Configuration centered on medical management and claims transparency capabilities, including utilization analytics dashboards, claims-based trend reporting, and workflows to surface potential denials and case management worklists. The MedeAnalytics SubPop Health deployment emphasized clinical review support for medical directors and case managers, aligning analytic outputs with utilization management decision processes.
Operational coverage emphasized California medical management functions, with the system used by medical directors and case managers to inform inpatient and outpatient utilization decisions. The implementation supported efforts to reduce denials and improve medical management by delivering actionable visibility into utilization patterns. SubPop Health usage is inferred, and separate employer and procurement capabilities added to MedeAnalytics via a 2024 acquisition could be leveraged for employer analytics scenarios.
|
|
|
Concerto Healthcare, Inc | Healthcare | 200 | $25M | United States | MedeAnalytics | MedeAnalytics SubPop Health | Predictive Analytics | 2020 | n/a |
In 2020, Concerto Healthcare, Inc implemented MedeAnalytics SubPop Health, a Predictive Analytics application, to stratify high risk Medicare Advantage members and to guide in home interventions across its U.S. population. The deployment leveraged MedeAnalytics population health predictive capabilities with the Johns Hopkins ACG add on to produce clinical risk scores and member stratification that informed outreach prioritization and care routing.
Implementation focused on configuring risk stratification and cohort identification workflows, care management dashboards, and referral orchestration to operationalize predictive signals. MedeAnalytics SubPop Health was used to surface high risk member lists, support clinician review workflows, and prioritize in home interventions and case management actions consistent with population health management practices.
Operational coverage centered on Medicare Advantage populations in the United States and involved care management, clinical operations, and utilization review teams who acted on predictive insights. Integrations were limited to operational workflow embedding rather than named technical system replacements, with predictive outputs routed into care pathways and clinician review processes to trigger in home visits and interventions.
Governance combined clinician validation of risk scores with care management oversight to ensure triage and intervention fidelity, and the program produced explicit projected outcomes. Concerto reported projected medical loss ratio improvements of 10% in 2021 and 20% in 2022, along with measurable reductions in hospitalizations, readmissions, and emergency department visits as a result of the MedeAnalytics Predictive Analytics deployment.
|
Buyer Intent: Companies Evaluating MedeAnalytics SubPop Health
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||